The LAT1-overexpressing cells established from MCF7 cells were unavailable and therefore we used S2-mock and S2-LAT1 cells which lost the cellular properties of tubular formation and contributed to drug discovery as normal-type and tumor-type stable cell lines. The gene discussed is LAT; the disease is neoplasm.